ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 42 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,000 | -30.0% | 7,191 | -40.4% | 0.00% | – |
| Q4 2017 | $10,000 | -9.1% | 12,062 | +72.2% | 0.00% | – |
| Q3 2017 | $11,000 | -8.3% | 7,006 | -4.0% | 0.00% | – |
| Q2 2017 | $12,000 | -62.5% | 7,295 | -49.7% | 0.00% | – |
| Q1 2017 | $32,000 | +100.0% | 14,498 | +77.7% | 0.00% | – |
| Q4 2016 | $16,000 | +23.1% | 8,160 | +82.8% | 0.00% | – |
| Q3 2016 | $13,000 | +550.0% | 4,464 | +197.0% | 0.00% | – |
| Q2 2016 | $2,000 | – | 1,503 | +686.9% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 191 | -36.3% | 0.00% | – |
| Q4 2015 | $1,000 | -75.0% | 300 | -83.3% | 0.00% | – |
| Q3 2015 | $4,000 | -90.9% | 1,800 | -88.5% | 0.00% | – |
| Q2 2015 | $44,000 | +41.9% | 15,713 | +355.1% | 0.00% | – |
| Q1 2015 | $31,000 | -6.1% | 3,453 | +23.2% | 0.00% | – |
| Q4 2014 | $33,000 | -2.9% | 2,803 | -8.7% | 0.00% | – |
| Q3 2014 | $34,000 | -24.4% | 3,071 | -10.1% | 0.00% | – |
| Q2 2014 | $45,000 | +21.6% | 3,417 | +47.0% | 0.00% | – |
| Q1 2014 | $37,000 | – | 2,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|